###begin article-title 0
###xml 93 96 93 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
Deciphering von Hippel-Lindau (VHL/Vhl)-Associated Pancreatic Manifestations by Inactivating Vhl in Specific Pancreatic Cell Populations
###end article-title 0
###begin p 1
Conceived and designed the experiments: HJS SL. Performed the experiments: HJS AA KY AW MH DL KP. Analyzed the data: HJS AW MH KP IAL SL. Contributed reagents/materials/analysis tools: HJS SMH KP DMH LSS ML SL. Wrote the paper: HJS.
###end p 1
###begin p 2
###xml 520 523 520 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 679 682 679 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 728 731 728 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 1037 1040 1030 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 1434 1437 1420 1423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 1691 1694 1677 1680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 300 308 <span type="species:ncbi:9606">patients</span>
###xml 527 531 <span type="species:ncbi:10090">mice</span>
###xml 1315 1320 <span type="species:ncbi:10090">mouse</span>
###xml 1367 1371 <span type="species:ncbi:10090">mice</span>
###xml 1404 1419 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1585 1589 <span type="species:ncbi:10090">mice</span>
###xml 1633 1641 <span type="species:ncbi:9606">patients</span>
The von Hippel-Lindau (VHL) syndrome is a pleomorphic familial disease characterized by the development of highly vascularized tumors, such as hemangioblastomas of the central nervous system, pheochromocytomas, renal cell carcinomas, cysts and neuroendocrine tumors of the pancreas. Up to 75% of VHL patients are affected by VHL-associated pancreatic lesions; however, very few reports in the published literature have described the cellular origins and biological roles of VHL in the pancreas. Since homozygous loss of Vhl in mice resulted in embryonic lethality, this study aimed to characterize the functional significance of VHL in the pancreas by conditionally inactivating Vhl utilizing the Cre/LoxP system. Specifically, Vhl was inactivated in different pancreatic cell populations distinguished by their roles during embryonic organ development and their endocrine lineage commitment. With Cre recombinase expression directed by a glucagon promoter in alpha-cells or an insulin promoter in beta-cells, we showed that deletion of Vhl is dispensable for normal functions of the endocrine pancreas. In addition, deficiency of VHL protein (pVHL) in terminally differentiated alpha-cells or beta-cells is insufficient to induce pancreatic neuroendocrine tumorigenesis. Most significantly, we presented the first mouse model of VHL-associated pancreatic disease in mice lacking pVHL utilizing Pdx1-Cre transgenic mice to inactivate Vhl in pancreatic progenitor cells. The highly vascularized microcystic adenomas and hyperplastic islets that developed in Pdx1-Cre;Vhl f/f homozygous mice exhibited clinical features similar to VHL patients. Establishment of three different, cell-specific Vhl knockouts in the pancreas have allowed us to provide evidence suggesting that VHL is functionally important for postnatal ductal and exocrine pancreas, and that VHL-associated pancreatic lesions are likely to originate from progenitor cells, not mature endocrine cells. The novel model systems reported here will provide the basis for further functional and genetic studies to define molecular mechanisms involved in VHL-associated pancreatic diseases.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 109 112 109 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VHL</italic>
###xml 390 393 390 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Couch1">[1]</xref>
###xml 465 468 465 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VHL</italic>
###xml 533 536 533 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Latif1">[2]</xref>
###xml 669 672 669 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Chen1">[3]</xref>
###xml 674 677 674 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Glavac1">[4]</xref>
###xml 734 737 734 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Linehan1">[5]</xref>
###xml 770 773 770 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VHL</italic>
###xml 893 896 893 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Friedrich1">[6]</xref>
###xml 898 901 898 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Hoffman1">[7]</xref>
###xml 903 906 903 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Ivanov1">[8]</xref>
###xml 908 911 908 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Pioli1">[9]</xref>
###xml 140 148 <span type="species:ncbi:9606">patients</span>
The von Hippel-Lindau (VHL) syndrome is an autosomal, dominant inherited disorder caused by mutations in the VHL tumor suppressor gene. VHL patients are predisposed to develop highly vascular tumors in multiple organs, including hemangioblastomas of the retina and central nervous system (CNS), clear cell renal carcinomas, pheochromocytomas, cyst and neuroendocrine tumors in the pancreas [1]. This familial cancer syndrome is caused by germ-line mutations in the VHL gene, which was mapped to chromosome 3p25 by positional cloning [2]. Following Knudson's two-hit hypothesis, loss or inactivation of the remaining wildtype allele is associated with VHL tumorigenesis [3], [4]. The spectrum of VHL tumors in affected families varies [5] and biochemical analysis of the VHL gene product has provided the molecular basis that explains the phenotype-genotype correlations evident in VHL disease [6], [7], [8], [9].
###end p 4
###begin p 5
###xml 304 308 296 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Iliopoulos1">[10]</xref>
###xml 310 314 302 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Maxwell1">[11]</xref>
###xml 666 670 646 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Clifford1">[12]</xref>
###xml 874 878 850 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Flamme1">[13]</xref>
###xml 984 988 956 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Cohen1">[14]</xref>
###xml 990 994 962 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Mukhopadhyay1">[15]</xref>
###xml 996 1000 968 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Pal1">[16]</xref>
###xml 1044 1048 1016 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Pal1">[16]</xref>
###xml 1050 1054 1022 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-EstebanBarragan1">[17]</xref>
###xml 1134 1138 1106 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Hergovich1">[18]</xref>
###xml 1207 1211 1179 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Ohh1">[19]</xref>
###xml 1213 1217 1185 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Tang1">[20]</xref>
###xml 865 873 <span type="species:ncbi:9606">patients</span>
At the molecular level, the von Hippel-Lindau protein (pVHL) is a critical factor in the oxygen sensing pathway. Under normoxic conditions, pVHL forms a multiprotein complex with E3 ubiquitin ligase that targets the alpha-subunits of hypoxia-inducible factor (HIFalpha) for degradation by the proteosome [10], [11]. Under hypoxic conditions, HIFalpha subunits escape ubiquitin-mediated proteolysis, allowing HIFalpha to accumulate, translocate to the nucleus, and activate downstream targets. In subsets of VHL mutations, the lack of functional pVHL leads to accumulation of HIF, and results in the activation of HIFalpha target genes even in the presence of oxygen [12]. Enhanced transcription of a wide variety of HIFalpha target genes, such as vascular endothelial growth factor (VEGF), is thought to contribute to the highly vascular tumors that develop in VHL patients [13]. Independent of its function in regulating the HIFalpha pathway, pVHL also binds other cellular proteins [14], [15], [16] and promotes extracellular matrix assembly [16], [17]. For example, pVHL has been shown to bind and stabilize microtubule structures [18], and regulate fibronectin deposition to maintain vascular integrity [19], [20].
###end p 5
###begin p 6
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VHL</italic>
###xml 125 128 125 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Latif1">[2]</xref>
###xml 130 134 130 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Kessler1">[21]</xref>
###xml 136 140 136 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Richards1">[22]</xref>
###xml 169 172 169 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 291 295 291 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Gnarra1">[23]</xref>
###xml 331 334 331 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 418 421 418 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 519 523 516 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Haase1">[24]</xref>
###xml 525 529 522 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Ma1">[25]</xref>
###xml 563 566 560 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 618 621 615 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 739 743 736 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Ma1">[25]</xref>
###xml 745 749 742 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Biju1">[26]</xref>
###xml 751 755 748 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Pfander1">[27]</xref>
###xml 782 785 779 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 940 944 937 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Rankin1">[28]</xref>
###xml 972 975 969 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 931 939 <span type="species:ncbi:9606">patients</span>
###xml 979 983 <span type="species:ncbi:10090">mice</span>
###xml 1122 1130 <span type="species:ncbi:9606">patients</span>
Expression of VHL has been reported in most tissues and cell types, but little is known about its role in normal development [2], [21], [22]. Homozygous inactivation of Vhl in mice resulted in embryonic lethality at embryonic stage (E) E10.5-E12.5 due to defects in placental vasculogenesis [23]. Thus, tissue-specific knockout of Vhl has been utilized to investigate the biological functions of pVHL. Inactivation of Vhl utilizing an albumin-cre in liver or a mosaic beta-actin-cre resulted in hepatic vascular tumors [24], [25], similar to the ones observed in Vhl heterozygous knockout animals. Unexpected roles of Vhl in spermatogenesis, thymus cell survival, and bone development have also been reported with conditional loss of pVHL [25], [26], [27]. Notably, inactivation of Vhl in renal epithelial cells led to development of tubular cysts that share morphologic and molecular characteristics with renal cysts found in VHL patients [28]. While genetic analysis of Vhl in mice have uncovered novel functions of pVHL in various tissues, much is yet to be learned about pVHL's role in organs normally affected in VHL patients, such as CNS, adrenals and pancreas.
###end p 6
###begin p 7
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Hough1">[29]</xref>
###xml 164 168 164 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Neumann1">[30]</xref>
###xml 321 325 321 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Binkovitz1">[31]</xref>
###xml 327 331 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Libutti1">[32]</xref>
###xml 559 562 559 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 814 817 807 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 7 15 <span type="species:ncbi:9606">patients</span>
###xml 149 157 <span type="species:ncbi:9606">patients</span>
###xml 197 205 <span type="species:ncbi:9606">patients</span>
###xml 437 445 <span type="species:ncbi:9606">patients</span>
###xml 483 488 <span type="species:ncbi:10090">mouse</span>
###xml 804 808 <span type="species:ncbi:10090">mice</span>
###xml 873 877 <span type="species:ncbi:10090">mice</span>
###xml 1092 1096 <span type="species:ncbi:10090">mice</span>
###xml 1164 1172 <span type="species:ncbi:9606">patients</span>
In VHL patients, the most common manifestations affecting the pancreas are benign cysts and microcystic adenomas (MCA), which occur in 35-75% of VHL patients [29], [30]. In addition, 12-17% of VHL patients develop pancreatic neuroendocrine (islet cell) tumors, which possess the malignant potential to develop metastasis [31], [32]. However, the cellular origins and molecular mechanisms leading to these pancreatic lesions found in VHL patients are not known. Here we present three mouse models of VHL in the pancreas generated by conditionally inactivating Vhl in specific pancreatic cell populations. Not previously reported in the literature, we showed that pVHL is dispensable for the normal functions of terminally differentiated islet alpha-cells and beta-cells in the endocrine pancreas. Whereas mice with Vhl deletion in endocrine pancreas showed normal survival, mice lacking pVHL in pancreatic progenitor cells that give arise to both exocrine and endocrine pancreas (Pdx1-Cre;Vhl f/f), exhibited significant postnatal death. Most significantly, the few surviving Pdx1-Cre;Vhl f/f mice developed MCA and islet hyperplasia, similar to those found in VHL patients. Taken together, these results provided evidence suggesting that pVHL is functionally important for postnatal exocrine pancreas, and that VHL-associated pancreatic lesions originate from progenitor cell lineages. The novel model systems reported here will provide the basis for further genetic studies to define molecular events involved in VHL-associated pancreatic diseases.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
Loss of pVHL in alpha-cells is Dispensable and Insufficient to Induce Tumorigenesis
###end title 9
###begin p 10
###xml 168 172 168 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Lubensky1">[33]</xref>
###xml 320 323 316 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 572 576 560 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Lobe1">[34]</xref>
###xml 859 868 839 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004897-g001">Figure 1A</xref>
###xml 77 85 <span type="species:ncbi:9606">patients</span>
###xml 437 440 <span type="species:ncbi:10116">rat</span>
###xml 567 571 <span type="species:ncbi:10090">mice</span>
###xml 989 993 <span type="species:ncbi:10090">mice</span>
VHL-associated pancreatic neuroendocrine tumors (PNET) afflict 12-17% of VHL patients, and these tumors have been demonstrated to exhibit focal positivity for glucagon [33]. Thus, we speculated that these PNET might originate from glucagon-positive alpha-cells deficient of pVHL in the endocrine pancreas. To inactivate Vhl specifically in alpha-cells, we first generated an alpha-cell specific Cre transgenic line (Glu-Cre) utilizing a rat glucagon promoter sequence to direct Cre recombinase expression. By crossing a Glu-Cre transgenic line with the Z/AP reporter mice [34], we confirmed alpha-cell specific expression of Cre recombinase in Glu-Cre;Z/AP pancreas at 5 and 12 months of age. As expected, expression of Cre-recombinase localized in alpha-cells at the outer ring of endocrine islets, as indicated by purple alkaline phosphatase (AP) staining (Figure 1A, right panels). No positive AP expression in pancreas was observed in age-matched control genotypes of Glu-Cre and Z/AP mice (data not shown).
###end p 10
###begin title 11
Analysis of Glu-Cre;Vhl colony.
###end title 11
###begin p 12
###xml 876 887 865 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-globin</italic>
###xml 1012 1015 998 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 586 590 <span type="species:ncbi:10090">mice</span>
A. Validation of the Glu-Cre transgenic line with Z/AP reporter mice. H&E (panels a, c, e) and alkaline phosphatase (AP; panels b, d, f) staining of a representative Glu-Cre;Z/AP pancreas at 5 months of age. Expression of Glu-Cre localized in alpha-cells at the outer ring of endocrine islets, as indicated by purple AP stain. Pancreatic islets (Is) are as indicated in panel a, and images are shown at 100x (a, b) and 400x (c, d, e, f) magnification. B. Genotyping PCR using genomic DNA isolated from different cell populations of the endocrine pancreas in Glu-Cre;Vhl f/f and Vhl f/f mice at 27 months of age. Insulin-positive beta-cells (I), glucagon-positive alpha-cells (G), and lectin-positive endothelial cells (L) were collected via flow cytometry. Negative (neg.) and positive (pos.) controls are shown next to the ladder (far left lane). Top panel shows the PCR for beta-globin alleles to demonstrate the presence of genomic DNA for each cell population. Bottom panel indicates the presence of deleted Vhl alleles only in alpha-cells of Glu-Cre;Vhl f/f pancreas.
###end p 12
###begin p 13
###xml 44 47 44 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 147 150 143 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 197 201 193 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Ma1">[25]</xref>
###xml 287 290 283 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 290 294 286 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Haase1">[24]</xref>
###xml 296 300 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Ma1">[25]</xref>
###xml 315 318 311 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 514 521 506 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004897-t001">Table 1</xref>
###xml 546 549 538 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 872 875 860 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 1137 1140 1118 1121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 1313 1322 1287 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004897-g001">Figure 1B</xref>
###xml 1367 1370 1341 1344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 1435 1438 1405 1408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 76 91 <span type="species:ncbi:10090">transgenic mice</span>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
###xml 524 529 <span type="species:ncbi:10090">Mouse</span>
###xml 850 854 <span type="species:ncbi:10090">mice</span>
###xml 923 927 <span type="species:ncbi:10090">mice</span>
To determine the functional significance of Vhl in alpha-cells, the Glu-Cre transgenic mice were next bred with mice in which exons 2 and 3 of the Vhl alleles are flanked by loxP sites (flox or f) [25]. Since variability in phenotype was documented in other tissue-specific knockouts of Vhl[24], [25], we generated Vhl-deficient alpha-cells in A/J and C57BL/6 backgrounds. At the time of weaning (3-4 weeks after birth), we obtained the expected Mendelian frequencies for all genotypes in both background strains (Table 1). Mouse pancreases with Vhl deletion in alpha-cells (Glu-Cre;Vhl f/f, n = 12) appeared histological normal when compared to age-matched control genotypes (Glu-Cre, n = 8 and Vhl f/f, n = 6) from 10 months to 23 months of age (data not shown). No obvious physiological and behavioral phenotypes were observed for Glu-Cre;Vhl f/f mice. To confirm that Vhl alleles were indeed deleted in Glu-Cre;Vhl f/f mice, we isolated alpha-cells, beta-cells and endothelial cells from pancreatic islets via flow cytometry, and obtained genomic DNA for each cell population. Genotyping PCR analysis showed the expected deletion of Vhl alleles only in glucagon-positive alpha-cells, but not in insulin-positive beta-cells and lectin-positive endothelial cells in Glu-Cre;Vhl f/f animals at 27 months of age (Figure 1B). Together, these results demonstrated that Vhl is not essential for mature alpha-cells, and that deficiency of Vhl in alpha-cells is insufficient to cause tumorigenesis in the endocrine pancreas.
###end p 13
###begin title 14
Expected Mendelian distribution in Glu-Cre;Vhl colony.
###end title 14
###begin p 15
###xml 16 20 <span type="species:ncbi:10090">mice</span>
Glu-Cre;Vhl f/+ mice were intercrossed and the genotypes of their offspring determined for each background strain at time of weaning.
###end p 15
###begin title 16
Vhl is not essential for Normal Function of Differentiated Islet beta-cell
###end title 16
###begin p 17
###xml 120 124 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Lubensky1">[33]</xref>
###xml 152 155 149 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 258 261 252 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 312 316 303 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Gannon1">[35]</xref>
###xml 357 360 348 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 601 608 592 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004897-t002">Table 2</xref>
###xml 821 831 812 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004897.s001">Figure S1A</xref>
###xml 1018 1021 1006 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 1135 1138 1123 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 1242 1252 1230 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004897.s001">Figure S1B</xref>
###xml 296 311 <span type="species:ncbi:10090">transgenic mice</span>
###xml 322 326 <span type="species:ncbi:10090">mice</span>
###xml 459 463 <span type="species:ncbi:10090">mice</span>
###xml 652 657 <span type="species:ncbi:10090">mouse</span>
###xml 945 949 <span type="species:ncbi:10090">mice</span>
Since beta-cells are the major cell type in the endocrine pancreas and some VHL PNETs are positive for insulin staining [33], we next hypothesized that Vhl deficiency in insulin-positive beta-cells might lead to PNET development. To conditionally inactivate Vhl in beta-cells, we crossed Rip-Cre transgenic mice [35] with mice in which exons 2 and 3 of the Vhl alleles are flanked by loxP sites (flox or f). Similar to our findings in the Glu-Cre;Vhl colony, mice from the Rip-Cre;Vhl colony were generated at the expected Mendelian frequencies for all genotypes regardless of the strain backgrounds (Table 2). Histological analysis of Rip-Cre;Vhl f/f mouse pancreases (n = 4) did not show any abnormality or islet tumor formation when compared to age-matched control genotypes (Rip-Cre and Vhl f/f) at 15 months of age (Figure S1A). Immuno-staining of endocrine markers, such as insulin and glucagon, did not reveal distinct features unique to mice deficient for pVHL in beta-cells (data not shown). Determination of Vhl allele status in the Rip-Cre;Vhl f/f pancreas utilizing DNA isolated from microdissection further confirmed that Vhl deletion only occurred in the expected endocrine islets, but not in the surrounding exocrine pancreas (Figure S1B).
###end p 17
###begin title 18
Expected Mendelian distribution in Rip-Cre;Vhl colony.
###end title 18
###begin p 19
###xml 16 20 <span type="species:ncbi:10090">mice</span>
Rip-Cre;Vhl f/+ mice were intercrossed and the genotypes of their offspring determined for each background strain at time of weaning.
###end p 19
###begin p 20
###xml 266 275 266 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004897-g002">Figure 2A</xref>
###xml 284 287 284 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 334 338 334 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Park1">[36]</xref>
###xml 677 686 677 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004897-g002">Figure 2B</xref>
###xml 804 808 804 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Gannon1">[35]</xref>
###xml 893 896 893 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 1205 1214 1205 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004897-g002">Figure 2C</xref>
###xml 1306 1309 1306 1309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 56 60 <span type="species:ncbi:10090">mice</span>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 407 411 <span type="species:ncbi:10090">mice</span>
###xml 509 513 <span type="species:ncbi:10090">mice</span>
###xml 643 647 <span type="species:ncbi:10090">mice</span>
###xml 788 803 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1173 1177 <span type="species:ncbi:10090">mice</span>
###xml 1279 1283 <span type="species:ncbi:10090">mice</span>
Notably, the physical appearance of the Rip-Cre;Vhl f/f mice were proportionally smaller than their littermates at time of weaning. Indeed, data confirmed that Rip-Cre;Vhl f/f mice weighed significantly less than age-matched littermates at all time points analyzed (Figure 2A). Since Vhl has been shown to regulate glucose metabolism [36], we next measured fasting glucose levels in a cohort of Rip-Cre;Vhl mice to determine if an elevated basal glucose level was responsible for the small size seen in these mice. However, our data demonstrated no significant differences in basal glucose levels between control genotypes and Rip-Cre;Vhl f/f mice at all time points measured (Figure 2B). We then speculated that low expression of Cre-recombinase in the hypothalamus reported for Rip-Cre transgenic mice [35] affects hormone feedback loops regulated by the hypothalamus due to inactivation of Vhl. Among various hormones regulated by the hypothalamus, we chose to measure growth hormone since its deficiency is associated with lean body mass. Again, our data did not show significant differences in serum growth hormone levels between control genotypes and Rip-Cre;Vhl f/f mice at all time points tested (Figure 2C). Therefore, it is unclear if the small size of Rip-Cre;Vhl f/f mice is due to the loss of Vhl in pancreatic islet beta-cells or in the hypothalamus.
###end p 20
###begin title 21
###xml 54 58 <span type="species:ncbi:10090">mice</span>
Physiological analyses of control and Rip-Cre;Vhl f/f mice.
###end title 21
###begin p 22
###xml 80 84 <span type="species:ncbi:10090">mice</span>
A. Body weight, B. Fasted glucose levels, and C. Serum growth hormone levels of mice in the Rip-Cre;Vhl colony. Genotypes are as indicated and numbers of animals analyzed at each time point are shown in tables. Data from three different strain backgrounds are combined and shown graphically.
###end p 22
###begin title 23
Vhl is Functionally Important for Postnatal Exocrine Pancreas
###end title 23
###begin p 24
###xml 137 141 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Hough1">[29]</xref>
###xml 143 147 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Neumann1">[30]</xref>
###xml 277 280 277 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 474 478 474 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Gu1">[37]</xref>
###xml 522 525 522 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 562 565 562 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 705 709 705 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Gu1">[37]</xref>
###xml 744 747 744 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 1029 1036 1022 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004897-t003">Table 3</xref>
###xml 128 136 <span type="species:ncbi:9606">patients</span>
###xml 390 405 <span type="species:ncbi:10090">transgenic mice</span>
###xml 501 516 <span type="species:ncbi:10090">transgenic mice</span>
###xml 533 537 <span type="species:ncbi:10090">mice</span>
###xml 552 556 <span type="species:ncbi:10090">mice</span>
###xml 726 730 <span type="species:ncbi:10090">mice</span>
###xml 825 829 <span type="species:ncbi:10090">mice</span>
###xml 980 984 <span type="species:ncbi:10090">mice</span>
The most common manifestations of pancreatic VHL disease are benign cysts and microcystic adenoma, which occur in 35-75% of VHL patients [29], [30]; however, it remains unclear whether these lesions arise from the endocrine or exocrine pancreas. To investigate whether loss of Vhl in the exocrine pancreas can lead to cyst development, we utilized pancreatic and duodenal homeobox 1 (Pdx1) transgenic mice in which cre recombinase expression was driven by the Pdx1 promoter [37]. By breeding Pdx1-Cre transgenic mice with Vhl floxed mice, we generated mice with Vhl deletion in pancreatic endocrine and exocrine cells as a result of Pdx1-Cre expression in pancreatic progenitor cells during embryogenesis [37]. In contrast to mice deficient in Vhl in alpha-cells or beta-cells, we observed some lethality in Pdx1-Cre;Vhl f/f mice. At the time of weaning, the distribution of genotypes was significantly different from the expected values with fewer than expected Pdx1-Cre;Vhl f/f mice in all three different genetic backgrounds (Table 3). Statistically, observed lethality is more severe in the A/J and Balb/C genetic backgrounds than in the C57BL/6 background.
###end p 24
###begin title 25
Lethality in generating Pdx1-Cre;Vhl f/f in A/J and Balb/C backgrounds.
###end title 25
###begin p 26
###xml 17 21 <span type="species:ncbi:10090">mice</span>
Pdx1-Cre;Vhl f/+ mice were intercrossed and the genotypes of their offspring determined for each background strain at time of weaning.
###end p 26
###begin p 27
###xml 224 231 224 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004897-t004">Table 4</xref>
###xml 608 617 608 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004897-g003">Figure 3A</xref>
###xml 640 643 640 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 854 857 854 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 933 936 933 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 1022 1031 1022 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004897-g003">Figure 3B</xref>
###xml 1096 1099 1096 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 1348 1351 1341 1344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
###xml 424 429 <span type="species:ncbi:10090">mouse</span>
###xml 1059 1063 <span type="species:ncbi:10090">mice</span>
###xml 1229 1233 <span type="species:ncbi:10090">mice</span>
To determine if the lethality in Pdx1-Cre;Vhl f/f mice occurs embryonically or postnatally, Mendelian ratios of the six possible genotypes were observed immediately after birth and during different postnatal time intervals (Table 4). The Pdx1-Cre;Vhl f/f mice were born at the anticipated Mendelian ratio; however, these mice could not survive more than 5 days postnatally (P5). We further analyzed whole-mount histology of mouse pups (P1-P5) in an attempt to uncover the cause of death. However, pathologists blinded for genotypes could not distinguish Pdx1-Cre;Vhl f/f pups from pups of control genotypes (Figure 3A). To confirm that the Vhl alleles were indeed deleted in the pancreas of Pdx1-Cre;Vhl f/f newborn pups, whole pup body DNA and pancreatic DNA were isolated by laser capture microdissection. Genotyping analysis demonstrated the expected Vhl deleted allele in the Pdx1-Cre;Vhl f/f pup pancreas, as well as the floxed Vhl allele in cells of non-pancreatic lineage, such as epithelial and endothelial cells (Figure 3B, animal #3). Thus, whereas mice with homozygous inactivation of Vhl in alpha-cells or beta- cells (Glu-Cre;Vhl f/f and Rip-Cre;Vhl f/f, respectively) showed normal survival rates, Pdx1-Cre;Vhl f/f mice exhibited reduced postnatal survival that is likely to be associated with exocrine dysfunction due to the loss of Vhl in the exocrine pancreas.
###end p 27
###begin title 28
Histological and molecular analyses of control and Pdx1-Cre;Vhl f/f pup pancreas.
###end title 28
###begin p 29
###xml 255 258 255 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 417 420 417 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 107 112 <span type="species:ncbi:10090">mouse</span>
###xml 599 604 <span type="species:ncbi:10090">mouse</span>
A. H&E staining of representative Pdx1-Cre, Vhl f/f (panels a and c) and control Pdx1-Cre (panels b and d) mouse pups at postnatal day 3 (P3). Magnified (50x) pup pancreas are shown (panels c and d), and islets are indicated by arrows. B. PCR analysis of Vhl allele status. DNA isolated from whole pup section (whole body DNA) and from pancreas via laser capture microdissection (LCM pancreas DNA) was used to detect Vhl allele status (floxed, wildtype-wt, deleted). Genotyping PCR was performed in duplicate for each pup (#1-#4). PCR results for Pdx1-Cre;Vhl f/f (#3)and Pdx1-Cre (#4) are the same mouse pups shown in A.
###end p 29
###begin title 30
###xml 36 40 <span type="species:ncbi:10090">mice</span>
Postnatal death in Pdx1-Cre;Vhl f/f mice.
###end title 30
###begin p 31
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004897-t004">Table 4</xref>
Table 4 combines data from A/J and Balb/C background strains and genotypes were determined at different postnatal (P) time points.
###end p 31
###begin title 32
###xml 103 111 <span type="species:ncbi:9606">Patients</span>
Loss of Vhl in Exocrine Pancreas Recapitulates Cysts and Microcystic Adenoma (MCA) That Develop in VHL Patients
###end title 32
###begin p 33
###xml 500 509 500 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004897-g004">Figure 4A</xref>
###xml 661 670 661 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004897-g004">Figure 4A</xref>
###xml 274 279 <span type="species:ncbi:10090">mouse</span>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
###xml 537 542 <span type="species:ncbi:10090">mouse</span>
###xml 626 630 <span type="species:ncbi:10090">mice</span>
Since the postnatal lethality observed for Pdx1-Cre;Vhl f/f did not exhibit 100% penetrance, we were able to perform histological analysis of the pancreases of the few surviving Pdx1-Cre;Vhl f/f at adulthood in the C57BL/6 background. At 6-7 months of age, Pdx1-Cre;Vhl f/f mouse pancreases (n = 2) were indistinguishable from control genotypes (data not shown). However, at 16-18 months of age, an obvious loss of exocrine pancreas and fat replacement were observed in Pdx1-Cre;Vhl f/f mice (n = 3, Figure 4A). Pathologists blinded for mouse genotypes further identified the presence of cysts and MCA in all Pdx1-Cre;Vhl f/f mice lacking pVHL in the pancreas (Figure 4A, panel c and f).
###end p 33
###begin title 34
Histological analysis of the microcystic adenomas (MCA) which developed in Pdx1-Cre;Vhl f/f adult pancreas.
###end title 34
###begin p 35
###xml 157 161 <span type="species:ncbi:10090">mice</span>
A. H&E staining of pancreas from representative control Pdx1-Cre (panel a), and Vhl f/+ (panel d), and two different Pdx1-Cre;Vhl f/f (panels b, c, e and f) mice at 16-18 months of age. Gross pancreas histology is shown at 40x in panels a, b, d, e., and areas (black boxes) in panels b and e are magnified at 200x in panels c and f. Islets are indicated by arrows and MCA are indicated by asterisk. B. Immuno-histochemical staining of MCA utilizing a CD31 antibody (top panel) and a pan-keratin MAK6 antibody (bottom panel) to identify endothelial cells and epithelial cells of MCA, respectively. Arrows indicate CD31 positive endothelial cells. Images shown are at 500x magnification. C. Representative immuno-fluorescent images of MCA, indicated by asterisks. FITC-lectin identifies endothelial cells, DAPI identifies cell nuclei and cytokeratin 18 identifies epithelial cells within MCA. Top panels are at 200x and bottom panels are at 400x magnification.
###end p 35
###begin p 36
###xml 191 195 191 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Mohr1">[38]</xref>
###xml 642 651 642 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004897-g004">Figure 4B</xref>
###xml 785 794 785 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004897-g004">Figure 4C</xref>
###xml 1068 1077 1068 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004897-g004">Figure 4C</xref>
###xml 7 15 <span type="species:ncbi:9606">patients</span>
###xml 304 312 <span type="species:ncbi:9606">patients</span>
###xml 732 736 <span type="species:ncbi:10090">mice</span>
In VHL patients, the pancreatic cysts and MCA are highly vascularized and characterized by a layer of epithelial lining intermixed with endothelial cells forming capillaries around the cysts [38]. To investigate the similarity between the MCA developed in Pdx1-Cre;Vhl f/f pancreas and that found in VHL patients, we used a CD31 antibody to identify endothelial cells, and a cocktail of cytokeratin antibodies (MAK6) to identify the epithelial cell lining of MCA. Immuno-histochemical staining revealed that epithelial lining of the MCA was positive for MAK6 but not CD31, and that CD31 positive endothelial cells were intermixed within MCA (Figure 4B). The extensive vasculature network of MCA was more evident in Pdx1-Cre;Vhl f/f mice injected with FITC-lectin prior to euthanizing (Figure 4C, panels a and b). Utilizing immuno-fluorescent staining, we further demonstrated that cytokeratin-positive epithelial lining and lectin-positive vasculature did not co-localize, but instead were distinctive cellular structures displayed by MCA in Pdx1-Cre;Vhl f/f animals (Figure 4C, panels c and d).
###end p 36
###begin p 37
###xml 193 202 193 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004897-g004">Figure 4A</xref>
###xml 250 259 250 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004897-g005">Figure 5A</xref>
###xml 427 436 427 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004897-g005">Figure 5B</xref>
Within the pancreas tissue largely replaced by fat deposition, some islets in Pdx1-Cre;Vhl f/f animals appeared small and abnormally shaped without much exocrine acinar cells surrounding them (Figure 4A, panel f), whereas some appeared hyperplastic (Figure 5A). Regardless of the size, islets of Pdx1-Cre;Vhl f/f were characterized by disorganized, dilated and tortuous vascular networks within, as well as outside the islets (Figure 5B). Since VHL neuroendocrine tumors are highly vascularized, it is possible that these islets lacking pVHL might be progressing toward developing pancreatic neuroendocrine tumors.
###end p 37
###begin title 38
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Histological analysis of the endocrine pancreas in Pdx1-Cre;Vhl f/f mice.
###end title 38
###begin p 39
###xml 101 105 <span type="species:ncbi:10090">mice</span>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
###xml 446 450 <span type="species:ncbi:10090">mice</span>
A. Immuno-fluorescent staining of representative pancreas in Pdx1-Cre (panel a) and Pdx1-Cre;Vhl f/f mice (panels b and c) to demonstrate the abnormally shaped and hyperplastic islets (red) in Pdx1-Cre;Vhl f/f mice at 16-18 months of age. Images are taken at 100x. B. Immuno-fluorescent images of representative pancreas in Pdx1-Cre (panels a-c) and Pdx1-Cre;Vhl f/f (panels d-i) to demonstrate hypervascularity within islets of Pdx1-Cre;Vhl f/f mice. Blood vessels are visualized via FITC-lectin injection (green; panels b, e, and h) while pancreatic islets are identified using an anti-insulin antibody (red; panels c, f, and i). Images are taken at 200x.
###end p 39
###begin title 40
###xml 104 108 <span type="species:ncbi:10090">Mice</span>
Modest Upregulation of Hif1alpha is Associated with Pancreatic Phenotypes Developed in Pdx1-Cre;Vhl f/f Mice
###end title 40
###begin p 41
###xml 129 133 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Maxwell1">[11]</xref>
###xml 337 346 325 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hif1&#945;</italic>
###xml 351 360 335 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hif2&#945;</italic>
###xml 390 399 370 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004897-g006">Figure 6A</xref>
###xml 415 424 395 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hif1&#945;</italic>
###xml 533 542 509 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hif2&#945;</italic>
###xml 549 558 521 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hif2&#945;</italic>
###xml 582 586 550 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vegf</italic>
###xml 588 592 556 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Raval1">[39]</xref>
###xml 653 662 621 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004897-g006">Figure 6A</xref>
###xml 707 716 675 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hif1&#945;</italic>
###xml 1088 1097 1044 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004897-g006">Figure 6B</xref>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
###xml 505 509 <span type="species:ncbi:10090">mice</span>
###xml 647 651 <span type="species:ncbi:10090">mice</span>
###xml 864 868 <span type="species:ncbi:10090">mice</span>
###xml 1048 1052 <span type="species:ncbi:10090">mice</span>
pVHL deficiency is known to result in constitutive HIF alpha-subunits stabilization and increased expression of HIF target genes [11]. To examine if the pancreatic phenotypes observed in Pdx1-Cre;Vhl f/f mice were associated with activation of Hif1alpha or Hif2alpha pathways, quantitative real-time PCR analysis was performed to detect Hif1alpha and Hif2alpha mRNA expression. As shown in Figure 6A, expression of Hif1alpha was upregulated in Pdx1-Cre;Vhl f/f pancreas (n = 3) when compared with control mice (n = 3). Expression of Hif2alpha and a Hif2alpha-preferred target gene (Vegf) [39] appeared similar between control and Pdx1-Cre;Vhl f/f mice (Figure 6A, data not shown). While the upregulation of Hif1alpha mRNA in Pdx1-Cre;Vhl f/f pancreas was not statistically significant, we speculated that this might be the reason why a few of the Pdx1-Cre;Vhl f/f mice survived postnatal lethality. Consistent with the mRNA data, we further confirmed the trend that protein expression of Hif1alpha was upregulated in the pancreas of pVHL deficient mice utilizing a Hif1alpha ELISA assay (Figure 6B).
###end p 41
###begin title 42
Expression analysis in Pdx1-Cre;Vhl f/f pancreas.
###end title 42
###begin p 43
###xml 278 282 <span type="species:ncbi:10090">mice</span>
Relative gene expression of Hif1alpha and Hif2alpha mRNA transcripts (A) and protein expression of Hif1alpha (B) in pancreas of control (Pdx1-Cre and Vhl f/+), and Pdx1-Cre;Vhl f/f genotypes at older than 16 months of age. Each column represents the average expression of three mice for the indicated genotype.
###end p 43
###begin title 44
Discussion
###end title 44
###begin p 45
###xml 311 314 311 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 400 404 393 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Herrera1">[40]</xref>
###xml 605 608 598 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 892 895 885 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VHL</italic>
###xml 1083 1086 1076 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VHL</italic>
###xml 80 85 <span type="species:ncbi:10090">mouse</span>
###xml 742 746 <span type="species:ncbi:10090">mice</span>
The major significance of this study is that generation of three new pancreatic mouse models of VHL has allowed us to address the cellular origins and biological roles of VHL during pancreatic development and tumorigenesis. In terms of VHL's role during pancreatic development, we demonstrated that deletion of Vhl in endocrine alpha-cells and beta-cells which terminally differentiated around E12.5 [40], does not appear to affect normal functions of endocrine pancreas during embryogenesis, postnatal development, and in adulthood (Glu-Cre;Vhl f/f and Rip-Cre;Vhl f/f animals). In contrast, deletion of Vhl in pancreatic progenitor cells that give arise to ductal, exocrine and endocrine pancreas resulted in significant postnatal death in mice (Pdx1-Cre;Vhl f/f animals), even though pancreatic organogenesis was not affected during embryonic development. Together, this data suggest that VHL is functionally important in postnatal ductal and exocrine pancreas, and that pVHL is not essential for mature endocrine pancreatic cells. While this finding uncovers the novel aspect of VHL in postnatal ductal and exocrine pancreas, it remains to be determined whether HIF-dependent or HIF-independent pathways are involved.
###end p 45
###begin p 46
###xml 333 336 333 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 545 548 545 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 682 685 682 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 783 786 783 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 1139 1143 1139 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Alpert1">[41]</xref>
###xml 1145 1149 1145 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Shorten1">[42]</xref>
###xml 1166 1170 1166 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Morohoshi1">[43]</xref>
###xml 1172 1176 1172 1176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Nyongo1">[44]</xref>
###xml 1319 1323 1319 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Blansfield1">[45]</xref>
###xml 1616 1620 1616 1620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Park2">[46]</xref>
###xml 1766 1769 1766 1769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 206 214 <span type="species:ncbi:9606">patients</span>
###xml 400 405 <span type="species:ncbi:10090">mouse</span>
###xml 497 505 <span type="species:ncbi:9606">patients</span>
###xml 671 675 <span type="species:ncbi:10090">mice</span>
###xml 751 755 <span type="species:ncbi:10090">mice</span>
###xml 769 773 <span type="species:ncbi:10090">mice</span>
###xml 866 870 <span type="species:ncbi:10090">mice</span>
###xml 1204 1212 <span type="species:ncbi:9606">patients</span>
In terms of VHL's role during pancreatic tumorigenesis, little is known about the cellular origins and molecular mechanisms related to VHL-associated pancreatic diseases, even though a large portion of VHL patients are affected by pancreatic manifestations, such as cysts, MCA and neuroendocrine tumors. By specifically inactivating Vhl in distinct pancreatic cell populations, we reported the first mouse model of VHL that recapitulates some of the clinical features found in the pancreas of VHL patients, and demonstrated that inactivation of Vhl in the endocrine pancreas is insufficient to initiate tumorigenesis. VHL-associated pancreatic lesions were only found in mice where Vhl was inactivated in pancreatic progenitor cells (Pdx1-Cre;Vhl f/f mice), but not in mice in which Vhl was inactivated in mature endocrine cells (Glu-Cre;Vhl f/f and Rip-Cre;Vhl f/f mice). Thus, our data supports the notion of a progenitor cell origin for these VHL-associated pancreatic lesions. In addition, it has been previously suggested by histopathological studies that MCA originated from pancreatic exocrine cells, such as the centroacinar cells [41], [42] or ductal cells [43], [44]. Moreover, none of the VHL patients (n>108) with PNET disease evaluated at our center had a functional neoplasm by hormone levels or symptoms [45]. Together, these data suggest that VHL-associated MCA and PNET originate from pancreatic ductal or exocrine progenitor cells, not differentiated endocrine cells. Analogous to our hypothesis, VHL-associated hemangioblastomas have been demonstrated to derive from embryologic multipotent cells [46]. However, further studies will be required to definitively determine if these VHL-associated pancreatic manifestations can be recapitulated when Vhl is specifically deleted in progenitor cells of ductal, exocrine or endocrine lineage.
###end p 46
###begin p 47
###xml 31 34 31 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 49 53 49 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Haase1">[24]</xref>
###xml 55 59 55 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Ma1">[25]</xref>
###xml 122 125 122 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 738 741 730 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VHL</italic>
###xml 1042 1046 1034 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Kurban1">[47]</xref>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 157 162 <span type="species:ncbi:10090">mouse</span>
###xml 228 232 <span type="species:ncbi:10090">mice</span>
###xml 449 453 <span type="species:ncbi:10090">mice</span>
###xml 567 571 <span type="species:ncbi:10090">mice</span>
###xml 899 903 <span type="species:ncbi:10090">mice</span>
###xml 1141 1145 <span type="species:ncbi:10090">mice</span>
Similar to pervious reports on Vhl knockout mice [24], [25], we also observed variability in phenotypic penetrance of the Vhl deletion due to differences in mouse genetic backgrounds. The postnatal lethality in Pdx1-Cre;Vhl f/f mice was most severe in A/J and Balb/C background strains, but not as severe in the C57BL/6 background strain. This finding suggests that strain-specific genetic modifiers may provide protection for the survival of these mice with pVHL deficiency in the pancreas. Notably, we showed that pancreatic phenotypes observed in Pdx1-Cre;Vhl f/f mice correlate with a modest upregulation of Hif1alpha, but not HIf2alpha. It is thus possible that these strain-specific genetic modifiers may function to interfere with VHL downstream signaling, and compensate for the loss of pVHL. This does not exclude the possibility that the pancreatic phenotypes observed in Pdx1-Cre;Vhl f/f mice resulted from mechanisms completely independent of HIF signaling pathways, such as VHL's role in regulating extracellular matrix assembly [47]. Identification of these modifier genes and further comparative functional analysis utilizing mice deficient in Hif1alpha and Hif2alpha will provide insight into the precise molecular mechanisms leading to the development of VHL-associated pancreatic disease.
###end p 47
###begin p 48
###xml 363 367 360 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Iliopoulos1">[10]</xref>
###xml 369 373 366 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Park1">[36]</xref>
###xml 745 749 739 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Gannon1">[35]</xref>
###xml 820 823 814 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 258 262 <span type="species:ncbi:10090">mice</span>
###xml 423 427 <span type="species:ncbi:10090">mice</span>
###xml 652 656 <span type="species:ncbi:10090">mice</span>
###xml 915 919 <span type="species:ncbi:10090">mice</span>
An unexpected observation during our studies was the small size seen in mice deficient in pVHL in the islet beta-cells. While our analyses excluded the idea that alterations in growth hormone and basal glucose levels led to this phenotype in Rip-Cre;Vhl f/f mice, it is described in the literature that pVHL regulates glucose metabolism in liver and kidney cells [10], [36]. Establishment of our Rip-Cre;Vhl f/f homozygous mice now allows us to begin investigating whether or not pVHL also plays an important role in glucose sensing in pancreatic islet beta-cells, such as via glucose transporter 1 (Glut1). However, phenotypes seen in Rip-Cre;Vhl f/f mice are confounded by the fact that Rip-Cre is expressed at a low level in the hypothalamus [35]. Thus, it would be critical to confirm and determine that deletion of Vhl indeed occurred in particular nuclei within the hypothalamus in Rip-Cre;Vhl f/f homozygous mice. Only when that information is available, will we be able to conclusively interpret the physiological data resulting from the loss of pVHL in pancreatic islet beta-cells or in the hypothalamus.
###end p 48
###begin p 49
###xml 143 146 143 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 210 215 <span type="species:ncbi:10090">mouse</span>
###xml 295 303 <span type="species:ncbi:9606">patients</span>
###xml 567 572 <span type="species:ncbi:10090">mouse</span>
In summary, to decipher the functional significance of pVHL in the pancreas during development and tumorigenesis, we conditionally inactivated Vhl in distinct pancreatic cell populations and reported the first mouse model of VHL that recapitulates clinical features found in the pancreas of VHL patients. Importantly, our data demonstrated that pVHL is functionally important for postnatal ductal and exocrine pancreas, and suggested that pancreatic progenitor cells, not mature endocrine cells, as the cell of origin for VHL-associated pancreatic lesions. The novel mouse model systems reported in this study will provide the foundation for further functional and genetic analysis to advance our understanding of VHL-associated pancreatic manifestations.
###end p 49
###begin title 50
Materials and Methods
###end title 50
###begin title 51
Ethics Statement
###end title 51
###begin p 52
National Cancer Institute (NCI) and NCI-Frederick are accredited by AAALAC International and follows the Public Health Service Policy for the Care and Use of Laboratory Animals. Animal care was provided in accordance with the procedures outlined in the "Guide for Care and Use of Laboratory Animals (National Research Council; 1996; National Academy Press; Washington DC). All animal experiments were conducted in accordance with NIH-approved protocols and guidelines.
###end p 52
###begin title 53
Animals and Genotyping
###end title 53
###begin p 54
###xml 18 21 18 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 52 56 52 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Ma1">[25]</xref>
###xml 229 233 229 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Gu1">[37]</xref>
###xml 807 811 807 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Lobe1">[34]</xref>
###xml 965 969 965 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LacZ</italic>
###xml 1006 1011 1006 1011 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hPLAP</italic>
###xml 1027 1032 1027 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hPLAP</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 147 162 <span type="species:ncbi:10090">transgenic mice</span>
###xml 177 192 <span type="species:ncbi:10090">transgenic mice</span>
###xml 280 295 <span type="species:ncbi:10090">transgenic mice</span>
###xml 375 390 <span type="species:ncbi:10090">transgenic mice</span>
###xml 532 535 <span type="species:ncbi:10116">rat</span>
###xml 767 782 <span type="species:ncbi:10090">transgenic mice</span>
###xml 802 806 <span type="species:ncbi:10090">mice</span>
###xml 846 861 <span type="species:ncbi:10090">transgenic mice</span>
###xml 937 941 <span type="species:ncbi:10090">mice</span>
Mice carrying the Vhl alleles flanked by loxP sites [25] were re-derived in C57BL/6, A/J and Balb/C backgrounds before crossing with different Cre transgenic mice. The Pdx1-Cre transgenic mice were a kind gift from Dr. D. Melton [37], and the Rip-Cre (B6.Cg-Tg (Ins2-cre)25Mgn/J) transgenic mice were purchased from The Jackson Laboratory (stock number: 003573). The Glu-Cre transgenic mice were generated utilizing the pBKCMV/Glu-CreGH plasmid kindly provided by Dr. M. Magnuson. Briefly, the plasmid fragment containing 2.3 kb of rat glucagon promoter upstream of the Cre-recombinase was isolated by SalI and NotI digestion prior to injection to generate transgenic founder lines. Tissue expression of Glu-Cre was evaluated in offspring from crosses of the Glu-Cre transgenic mice with Z/AP reporter mice [34]. Detailed analysis of the Glu-Cre transgenic mice will be described elsewhere. Cre recombinase expression in tissues of Z/AP mice will delete the floxed LacZ expression cassette upstream of the hPLAP gene, allowing hPLAP expression and detection by standard staining techniques. Tissue sections were counterstained with nuclear fast red (Sigma, St. Louis, MO).
###end p 54
###begin p 55
###xml 778 803 765 790 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTGAAACAAGTGCAGGTGTTCG</named-content>
###xml 814 840 801 827 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCTGAAGATATAGAAGATAATCG</named-content>
###xml 869 892 856 879 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AAAATGCAGGCAGATGAGCA</named-content>
###xml 903 925 890 912 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAGGCTGTTGGCGAAGACA</named-content>
###xml 958 993 942 977 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCAATCTGCTCACACAGGATAGAGAGGGCAGG</named-content>
###xml 1004 1039 988 1023 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCTTGAGGCTGTCCAAGTGATTCAGGCCATCG</named-content>
###xml 1174 1177 1158 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vhl</italic>
###xml 1206 1210 1190 1194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Hong1">[48]</xref>
###xml 4 8 <span type="species:ncbi:10090">mice</span>
All mice were genotyped by PCR using DNA isolated from tail snips. Tails were digested overnight in 150 microl of DirectPCR Lysis buffer (Viagen Biotech, Los Angeles, CA) following manufacturer's protocol, and used directly for PCR. Cells collected from laser capture microdissection (LCM) and flow cytometry were digested overnight in buffer (100 mM Tris-Cl pH8.0, 50 mM EDTA, 0.2% SDS, 200 mM NaCl) containing fresh proteinase K (1 mg/ml). Genomic DNA was isolated following a standard salt and ethanol precipitation protocol. DNA concentration was determined using NanoDrop ND-1000 (NanoDrop, Wilmington, DE), and equal amounts of DNA were used for PCR analysis. The annealing temperature for Pdx1-Cre, Glu-Cre, and beta-globin was 55degreesC. Primers for Pdx1-Cre (forward: 5'-TTGAAACAAGTGCAGGTGTTCG; reverse: 5'-CCTGAAGATATAGAAGATAATCG), and for Glu-Cre (forward: 5'-AAAATGCAGGCAGATGAGCA; reverse: 5'-CAGGCTGTTGGCGAAGACA), and for beta-globin (forward: 5'-CCAATCTGCTCACACAGGATAGAGAGGGCAGG; reverse: 5'-CCTTGAGGCTGTCCAAGTGATTCAGGCCATCG) were utilized to generate 500 bp, 401 bp, and 494 bp PCR products, respectively. The PCR conditions for detecting floxed and deleted Vhl alleles have been described [48].
###end p 55
###begin title 56
Animal Tissue Collection and Processing
###end title 56
###begin p 57
###xml 374 378 <span type="species:ncbi:10090">mice</span>
###xml 470 474 <span type="species:ncbi:10090">mice</span>
###xml 552 557 <span type="species:ncbi:10090">mouse</span>
###xml 658 663 <span type="species:ncbi:10090">Mouse</span>
The pancreatic tissue was processed for frozen histological analysis by embedding tissues in Tissue-Tek OCT freezing medium, and for formalin-fixed paraffin embedding (FFPE). Frozen (10-20 microm) and FFPE pancreas sections (5 microm) were routinely stained with Mayer's hematoxylin and eosin (H&E) for histopathological analysis. For all histological analysis, Cre;Vhl f/f mice were compared with age-matched controls genotypes of Cre, Vhl f/f, Vhl f/+ and Cre;Vhl f/+ mice. Only representative control genotypes are shown in figures. For whole mount mouse pup analysis, a sagittal incision was made to allow formalin fixation to penetrate internal organs. Mouse pups were divided into two parts via the sagittal incision prior to the paraffin embedding process.
###end p 57
###begin p 58
###xml 84 88 84 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Thurston1">[49]</xref>
###xml 180 203 180 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lycopersicon esculentum</italic>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 180 203 <span type="species:ncbi:4081">Lycopersicon esculentum</span>
###xml 294 298 <span type="species:ncbi:10090">mice</span>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
FITC-lectin perfusion to visualize the blood vasculature was performed as described [49]. Briefly mice were injected intravenously via tail vein with 50 ug of FITC-labeled lectin (Lycopersicon esculentum, Vector Laboratories, Burlingame, CA), which was allowed to circulate for 3 minutes. Then mice were euthanized via cervical dislocation, and the pancreas was removed. All procedures involving mice were performed with approval by the NIH Institutional Animal Care and Use Committee.
###end p 58
###begin title 59
Islet Isolation, Dissociation, and Flow Cytometry
###end title 59
###begin p 60
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were perfused with FITC-lectin as described above prior to being euthanized. Pancreatic islets were isolated by standard techniques, with minor adaptations. Briefly, pancreata were inflated via bile duct cannulation and retrograde pancreatic duct injection of 3-4 ml of ice-cold collagenase type XI (1 mg/ml in HBSS, Sigma, St. Louis, MO). Following digestion (37degreesC, 14 min), pancreata were dispersed by gently aspirating through a 14G needle, then filtered through a metal strainer (0.8 mm). Pancreas suspensions were then subjected to buoyant density gradient centrifugation (14-15% Optiprep, Accurate Chemicals, Westbury, NY), followed by handpicking with great care to collect all visible islets.
###end p 60
###begin p 61
###xml 165 167 165 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 511 517 <span type="species:ncbi:9913">bovine</span>
###xml 640 650 <span type="species:ncbi:10141">guinea pig</span>
###xml 852 857 <span type="species:ncbi:10090">mouse</span>
###xml 981 991 <span type="species:ncbi:10141">guinea pig</span>
Isolated islets were dissociated into single cell suspensions by careful pipeting after washing in 2 mM EDTA/PBS, and incubation for 10 min at room temperature in Ca2+ free phosphate buffered saline (PBS) supplemented with 0.025% trypsin. Dissociated islet cells were immediately fixed and permeabilized in 4% paraformaldehyde (PFA) (Electron Microscopy Sciences, Hatfield, PA), 0.1% saponin, (Fluka Chemicals, Switzerland) in PBS for 30 min at room temperature. After removing PFA by washing in 0.1 saponin/1% bovine serum albumin (BSA)/PBS, islet cells were stained intracytoplasmically for 30 min with antibodies against insulin (1:300, guinea pig, DAKO, Carpinteria, CA). After washing, cells were stained in a second staining step with an glucagon monoclonal antibody (clone K79bB10, Sigma, St. Louis, MO) using Zenon (pre)labeling technology for mouse IgG1 (Pacific Blue, Invitrogen, Carlsbad, CA), and an highly cross-absorbed, second-step polyclonal antibodies (pAb), anti-guinea pig-Cy5 (Jackson ImmunoResearch, West Grove, PA). After the final wash in 1%BSA/saponin, cells were post-fixed in 1% PFA, and concomitantly 4-way sorted for insulin positive, glucagon positive, FITC-lectin positive and unstained samples using a FACSAria cell sorter with Diva software (BD Biosciences, San Jose, CA). Electronic gating was set to include viable cells on the basis of forward scatter versus side scatter while the doublet-exclusion gating setup was applied to eliminate non-dissociated islet cell couplets on the basis of pulse width versus total signal area (linear scale). Sorted islet cell subsets were washed in PBS and kept frozen at -70degreesC until DNA extraction.
###end p 61
###begin title 62
Growth Hormone Measurements
###end title 62
###begin p 63
###xml 119 124 <span type="species:ncbi:10090">Mouse</span>
###xml 125 128 <span type="species:ncbi:10116">Rat</span>
Whole blood was collected via orbital or mandible bleed to isolate serum. Growth hormone levels were measured with the Mouse/Rat Growth Hormone ELISA (Diagnostic Systems Labroatories, Inc., Webster, TX) according to the manufacturer's instructions.
###end p 63
###begin title 64
Glucose Measurements
###end title 64
###begin p 65
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice underwent a 24 hour fast prior to collecting whole blood via a tail snip. Blood glucose was measured using a glucometer (Ascensia Contour, Bayer HealthCare, Mishawaka, IN).
###end p 65
###begin title 66
Immuno-Staining for Histological Analysis
###end title 66
###begin p 67
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
###xml 57 62 <span type="species:ncbi:9606">human</span>
###xml 140 145 <span type="species:ncbi:10090">mouse</span>
###xml 299 310 <span type="species:ncbi:3704">Horseradish</span>
For immuno-histochemical staining, monoclonal mouse anti-human CD31 (1:25, DAKO clone JC70A, Carpinteria, CA) antibodies, and a cocktail of mouse-anti-cytokeratin, or MAK6 antibodies (predilute, Invitrogen, Carlsbad, CA) were used. The Universal DakoCytomation Labelled Streptavidin-Biotin2 System, Horseradish Peroxidase (LSAB2 System, HRP) followed by the additiona of DAB chromogen was utilized for antigen detection. Sections were counterstained in Mayer's hematoxylin, mounted and photographed using a Zeiss microscope.
###end p 67
###begin p 68
###xml 172 176 <span type="species:ncbi:9925">goat</span>
###xml 220 230 <span type="species:ncbi:10141">guinea pig</span>
###xml 236 241 <span type="species:ncbi:9823">swine</span>
###xml 285 291 <span type="species:ncbi:9986">rabbit</span>
###xml 585 595 <span type="species:ncbi:10141">guinea pig</span>
###xml 633 639 <span type="species:ncbi:9986">rabbit</span>
For immuno-staining of FITC-lectin injected pancreas, frozen sections were briefly fixed in 4% paraformaldehyde, washed in PBS, and incubated in blocking buffer (5% normal goat serum/2.5% BSA in PBS). Primary antibodies guinea pig anti-swine insulin (1:500, DAKO, Carpinteria, CA) and rabbit anti-cytokeratin 18 (1:50, Santa Cruz Biotechnology, Santa Cruz, CA) were diluted in 0.5x blocking buffer. Sections were incubated with primary antibody overnight at 4degreesC in a humidified chamber followed by brief washes in PBS. Secondary antibodies Alexa Fluor 594 or 633-conjugated anti-guinea pig and Alexa Fluor 594 -conjugated anti-rabbit (1:200; Invitrogen, Carlsbad, CA) were applied to sections. After incubation at room temperature for one hour, the fluorescently stained sections were washed several times in PBS, cover slipped using mounting medium with DAPI (Vector Laboratories, Burlingame, CA), and visualized using either a Zeiss Axiovert fluorescence microscope (Carl Zeiss MicroImaging, Thornwood, NY).
###end p 68
###begin title 69
RNA collection and Quantitative Real-Time PCR
###end title 69
###begin p 70
###xml 398 402 394 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004897-Shen1">[50]</xref>
Islet RNA was collected from frozen pancreas sections on slides by microdissection and extracted using the PicoPure RNA Isolation kit (Arcturus, Mountain View, CA). RNA concentration was determined by NanoDrop ND-1000 (NanoDrop, Wilmington, DE), and equal amounts (1.4 microg) of total RNA was used to generate cDNA. Reverse transcription and quantitative PCR was performed as described previously [50]. TaqMan primers and probes were purchased from Applied Biosystems (Foster City, CA): Gapdh (Mm99999915_g1), Hif1alpha (Mm00468878_m1), Hif2alpha/Epas1 (Mm0438717_m1).
###end p 70
###begin title 71
Hif1alpha ELISA
###end title 71
###begin p 72
###xml 305 310 <span type="species:ncbi:10090">Mouse</span>
###xml 360 365 <span type="species:ncbi:9606">human</span>
###xml 366 371 <span type="species:ncbi:10090">mouse</span>
Total pancreatic protein lysate was harvested by sonicating pancreas on ice in RIPA buffer (Pierce, Rockford, IL) containing 1x Complete Protease Inhibitor Cocktail (Roche, Nutley, NJ). Protein concentration was determined with the Quick Start Bradford Protein Assay (Bio-Rad Laboratories, Hercules, CA). Mouse Hif1alpha protein was measured using Surveyor IC human/mouse total Hif1alpha immunoassay according to manufacturer's protocols (R&D Systems, Minneapolis, MN).
###end p 72
###begin title 73
Statistical Analysis
###end title 73
###begin p 74
###xml 151 155 <span type="species:ncbi:10090">mice</span>
###xml 349 354 <span type="species:ncbi:10090">Mouse</span>
Statistical analysis was performed using GraphPad Prism v.5.01 and Microsoft Excel. The distributions of genotypes after inter-breeding of Cre;Vhl f/+ mice were compared to the expected Mendelian distributions with Chi-square-test. Chi-square and p-value (2 degrees of freedom) are indicated for each strain and each postnatal time point in Tables. Mouse body weight, serum growth hormone levels, and fasted blood glucose levels were evaluated with one-way ANOVA with multiple comparisons testing. Expression data of Hif1alpha and Hif2alpha were analyzed with Mann-Whitney (unpaired, nonparametric) t-test. A p value less than (<) 0.05 was considered statistically significant.
###end p 74
###begin title 75
Supporting Information
###end title 75
###begin p 76
###xml 309 313 <span type="species:ncbi:10090">mice</span>
A. H&E staining of representative Rip-Cre and Rip-Cre;Vhl f/f pancreas at 15 months of age. Islets are as indicated (Is), and images are taken at 100x. B. Genotyping PCR to determine Vhl allele status using genomic DNA isolated from exocrine (exo) and endocrine (endo) pancreas in Rip-Cre;Vhl f/f and Rip-Cre mice at 12 months of age.
###end p 76
###begin p 77
(2.54 MB TIF)
###end p 77
###begin p 78
Click here for additional data file.
###end p 78
###begin p 79
###xml 234 239 <span type="species:ncbi:9606">Human</span>
We gratefully thank Dr. V. Keck for technical assistance, and Drs. A. Tandle and M. Kwon for their insightful comments. The content of this publication does not necessarily reflect the views or policies of the Department of Heath and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.
###end p 79
###begin title 80
References
###end title 80
###begin article-title 81
von Hippel-Lindau disease.
###end article-title 81
###begin article-title 82
Identification of the von Hippel-Lindau disease tumor suppressor gene.
###end article-title 82
###begin article-title 83
Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.
###end article-title 83
###begin article-title 84
Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central Europe.
###end article-title 84
###begin article-title 85
Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer.
###end article-title 85
###begin article-title 86
Genotype-phenotype correlation in von Hippel-Lindau syndrome.
###end article-title 86
###begin article-title 87
von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.
###end article-title 87
###begin article-title 88
###xml 82 87 <span type="species:ncbi:9606">human</span>
Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer.
###end article-title 88
###begin article-title 89
The von Hippel-Lindau protein interacts with heteronuclear ribonucleoprotein a2 and regulates its expression.
###end article-title 89
###begin article-title 90
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
###end article-title 90
###begin article-title 91
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.
###end article-title 91
###begin article-title 92
Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease.
###end article-title 92
###begin article-title 93
Up-regulation of vascular endothelial growth factor in stromal cells of hemangioblastomas is correlated with up-regulation of the transcription factor HRF/HIF-2alpha.
###end article-title 93
###begin article-title 94
An important von Hippel-Lindau tumor suppressor domain mediates Sp1-binding and self-association.
###end article-title 94
###begin article-title 95
The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity.
###end article-title 95
###begin article-title 96
The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways.
###end article-title 96
###begin article-title 97
Role of the von Hippel-Lindau tumor suppressor gene in the formation of beta1-integrin fibrillar adhesions.
###end article-title 97
###begin article-title 98
Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL.
###end article-title 98
###begin article-title 99
The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix.
###end article-title 99
###begin article-title 100
pVHL function is essential for endothelial extracellular matrix deposition.
###end article-title 100
###begin article-title 101
###xml 67 72 <span type="species:ncbi:9606">human</span>
###xml 97 102 <span type="species:ncbi:10090">mouse</span>
Expression of the Von Hippel-Lindau tumor suppressor gene, VHL, in human fetal kidney and during mouse embryogenesis.
###end article-title 101
###begin article-title 102
###xml 74 79 <span type="species:ncbi:9606">human</span>
Expression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesis.
###end article-title 102
###begin article-title 103
###xml 79 83 <span type="species:ncbi:10090">mice</span>
Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice.
###end article-title 103
###begin article-title 104
Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor.
###end article-title 104
###begin article-title 105
###xml 89 93 <span type="species:ncbi:10090">mice</span>
Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene.
###end article-title 105
###begin article-title 106
Vhlh gene deletion induces Hif-1-mediated cell death in thymocytes.
###end article-title 106
###begin article-title 107
Deletion of Vhlh in chondrocytes reduces cell proliferation and increases matrix deposition during growth plate development.
###end article-title 107
###begin article-title 108
###xml 26 30 <span type="species:ncbi:10090">mice</span>
Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor.
###end article-title 108
###begin article-title 109
Pancreatic lesions in von Hippel-Lindau disease: prevalence, clinical significance, and CT findings.
###end article-title 109
###begin article-title 110
Pancreatic lesions in the von Hippel-Lindau syndrome.
###end article-title 110
###begin article-title 111
Islet cell tumors in von Hippel-Lindau disease: increased prevalence and relationship to the multiple endocrine neoplasias.
###end article-title 111
###begin article-title 112
Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations.
###end article-title 112
###begin article-title 113
###xml 76 84 <span type="species:ncbi:9606">patients</span>
Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis.
###end article-title 113
###begin article-title 114
Z/AP, a double reporter for cre-mediated recombination.
###end article-title 114
###begin article-title 115
###xml 53 56 <span type="species:ncbi:10116">rat</span>
###xml 97 102 <span type="species:ncbi:10090">mouse</span>
Analysis of the Cre-mediated recombination driven by rat insulin promoter in embryonic and adult mouse pancreas.
###end article-title 115
###begin article-title 116
von Hippel Lindau tumor suppressor regulates hepatic glucose metabolism by controlling expression of glucose transporter 2 and glucose 6-phosphatase.
###end article-title 116
###begin article-title 117
Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors.
###end article-title 117
###begin article-title 118
###xml 127 135 <span type="species:ncbi:9606">patients</span>
Histopathology and molecular genetics of multiple cysts and microcystic (serous) adenomas of the pancreas in von Hippel-Lindau patients.
###end article-title 118
###begin article-title 119
Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma.
###end article-title 119
###begin article-title 120
###xml 36 40 <span type="species:ncbi:10090">mice</span>
Pancreatic cell lineage analyses in mice.
###end article-title 120
###begin article-title 121
Microcystic adenoma (serous cystadenoma) of the pancreas. A study of 14 cases with immunohistochemical and electron-microscopic correlation.
###end article-title 121
###begin article-title 122
Microcystic adenomas (serous cystadenomas) of pancreas. A clinicopathologic investigation of eight cases with immunohistochemical and ultrastructural studies.
###end article-title 122
###begin article-title 123
Exocrine pancreatic tumours and their histological classification. A study based on 167 autopsy and 97 surgical cases.
###end article-title 123
###begin article-title 124
Microcystic adenoma of the pancreas with myoepithelial cells. A hitherto undescribed morphologic feature.
###end article-title 124
###begin article-title 125
###xml 51 59 <span type="species:ncbi:9606">patients</span>
Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs).
###end article-title 125
###begin article-title 126
von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells.
###end article-title 126
###begin article-title 127
Characterization of a von Hippel Lindau pathway involved in extracellular matrix remodeling, cell invasion, and angiogenesis.
###end article-title 127
###begin article-title 128
###xml 83 88 <span type="species:ncbi:10090">mouse</span>
Vascular defects and liver damage by the acute inactivation of the VHL gene during mouse embryogenesis.
###end article-title 128
###begin article-title 129
Permeability-related changes revealed at endothelial cell borders in inflamed venules by lectin binding.
###end article-title 129
###begin article-title 130
Parathyroid tumor development involves deregulation of homeobox genes.
###end article-title 130
###begin p 131
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 131
###begin p 132
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This research was supported in part by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute (NCI), and with federal funds from the NIH-NCI, under contract HHSN261200800001E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 132

